Loading...
Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia
Acute myeloid leukemia (AML) is a cancer of the myeloid lineage of blood cells. Although significant progress has been made in treating many types of cancers during recent years, AML remains a deadly disease with survival rate lagging behind other blood cancers. A combination of toxic chemotherapies...
Saved in:
| Published in: | Stem Cell Investig |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5460107/ https://ncbi.nlm.nih.gov/pubmed/28607922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/sci.2017.05.04 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|